Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Sell
4,024
-232
-5% -$12K ﹤0.01% 932
2026
Q1
$216K Buy
4,256
+965
+29% +$45K ﹤0.01% 965
2025
Q4
$97K Sell
3,291
-2,137
-39% -$58.1K ﹤0.01% 1338
2025
Q3
$140K Sell
5,428
-523
-9% -$14.6K ﹤0.01% 1117
2025
Q2
$164K Buy
5,951
+997
+20% +$26.3K ﹤0.01% 1007
2025
Q1
$140K Buy
4,954
+1,336
+37% +$47.4K ﹤0.01% 1051
2024
Q4
$150K Buy
3,618
+535
+17% +$25.6K ﹤0.01% 1012
2024
Q3
$206K Sell
3,083
-3,605
-54% -$331K ﹤0.01% 848
2024
Q2
$794K Buy
6,688
+1,579
+31% +$200K 0.02% 369
2024
Q1
$544K Buy
5,109
+1,528
+43% +$154K 0.01% 478
2023
Q4
$356K Sell
3,581
-502
-12% -$42.2K 0.01% 583
2023
Q3
$422K Buy
4,083
+824
+25% +$91.9K 0.01% 497
2023
Q2
$396K Sell
3,259
-253
-7% -$33.8K 0.01% 520
2023
Q1
$539K Sell
3,512
-773
-18% -$128K 0.01% 402
2022
Q4
$770K Buy
4,285
+1,410
+49% +$231K 0.02% 281
2022
Q3
$340K Sell
2,875
-1,212
-30% -$184K 0.01% 500
2022
Q2
$584K Buy
4,087
+384
+10% +$54.9K 0.02% 330
2022
Q1
$638K Buy
3,703
+522
+16% +$87.9K 0.02% 330
2021
Q4
$808K Sell
3,181
-631
-17% -$184K 0.02% 256
2021
Q3
$1.47M Buy
3,812
+1,386
+57% +$511K 0.05% 131
2021
Q2
$570K Buy
2,426
+399
+20% +$71.3K 0.02% 315
2021
Q1
$265K Buy
2,027
+642
+46% +$93K 0.01% 488
2020
Q4
$145K Buy
1,385
+716
+107% +$72.4K 0.01% 644
2020
Q3
$47K Buy
669
+469
+235% +$32.7K ﹤0.01% 1016
2020
Q2
$13K Buy
200
+146
+270% +$8K ﹤0.01% 1477
2020
Q1
$2K Buy
+54
New +$1.24K ﹤0.01% 1971
2019
Q3
Sell
-2
Closed 2164
2019
Q2
$0 Hold
2
﹤0.01% 2118
2019
Q1
$0 Hold
2
﹤0.01% 2024
2018
Q4
$0 Buy
+2
New +$33 ﹤0.01% 2021

Other funds holding MRNA

SignatureFD's MRNA Position: Q2 2026 in Review

SignatureFD reduced its Moderna (MRNA) stake by 5.5% in Q2 2026, selling an estimated $12K and leaving 4,024 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

SignatureFD first reported a position in MRNA in Q4 2018 and has held it in 29 quarters since. The position peaked at $1.47M in Q3 2021. 166 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • SignatureFD held 4,024 shares of Moderna worth $282K as of Q2 2026.
  • SignatureFD sold 232 Moderna shares in Q2 2026, an estimated $12K.
  • Moderna made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #932 holding.
  • SignatureFD first reported a position in Moderna in Q4 2018 and has held it in 29 quarters since.
  • SignatureFD's Moderna position peaked at $1.47M in Q3 2021.
  • 166 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.